Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local injection of human adipose-derived mesenchymal stem cells for localized scleroderma with skin sclerosis of the face, head, and limbs
CTR20254587Phase 2Active
- Sponsor
- Beijing Aige Stem Cell Technology
- Start
- Jan 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human adipose-derived mesenchymal stem cells for injection in morphea, sponsored by Beijing Aige Stem Cell Technology. Started Jan 2026; status: active.
02
Drugs
human adipose-derived mesenchymal stem cells for injection
03
Conditions
morphea
Beyond the preview
Go deeper on CTR20254587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254587.